ClinConnect ClinConnect Logo
Search / Trial NCT06875999

Pet Therapy Effects on Pain, Emotional and Physiological Responses in Children Undergoing Allergy Testing

Launched by MEHTAP METİN KARAASLAN · Mar 12, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Allergy Testing Children Animal Assisted Therapy Emotions

ClinConnect Summary

In recent years, there has been a marked increase in the prevalence of allergic diseases. In particular, the incidence of allergic respiratory diseases has almost doubled in the last two decades. This increase is thought to be related to increased sensitization to both indoor and outdoor allergens. Indoors, house dust mites remain the most important cause of allergic sensitization in infants. With increasing age, the prevalence of aeroallergens, especially pollen, increases and sensitization to indoor and outdoor allergens reaches similar levels around three years of age. Sensitization to b...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • No previous allergy testing
  • 3-6 years old
  • Stable hemodynamics
  • No chronic disease
  • The child has no intellectual or neurological disability
  • The mother has no obstacle to communication
  • Mother is literate
  • Families and children agree to participate in the study.
  • Exclusion Criteria:
  • The child does not meet the inclusion criteria
  • The mother does not meet the inclusion criteria
  • Child's and mother's unwillingness to participate in the study

About Mehtap Meti̇n Karaaslan

Mehtap Metin Karaaslan is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, Ms. Karaaslan leads initiatives that prioritize rigorous study design, ethical standards, and regulatory compliance. Her expertise spans various therapeutic areas, and she fosters collaboration among multidisciplinary teams to ensure the successful execution of clinical trials. Through her leadership, she aims to contribute significantly to the development of novel therapies and improve the overall landscape of healthcare.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported